A prospective multicentre diagnostic accuracy study for the Truenat tuberculosis assays

BACKGROUND: Bringing reliable and accurate tuberculosis (TB) diagnosis closer to patients is a key priority for global TB control. Molbio Diagnostics have developed the Truenat point-of-care molecular assays for detection of TB and rifampicin (RIF) resistance. METHODS: We conducted a prospective mul...

Descripción completa

Detalles Bibliográficos
Autores principales: Penn-Nicholson, Adam, Gomathi, Sivaramakrishnan N., Ugarte-Gil, Cesar, Meaza, Abyot, Lavu, Evelyn, Patel, Pranav, Choudhury, Bandana, Rodrigues, Camilla, Chadha, Sarabjit, Kazi, Mubin, Macé, Aurélien, Nabeta, Pamela, Boehme, Catharina, Gangakhedkar, Raman R., Sarin, Sanjay, Tesfaye, Ephrem, Gotuzzo, Eduardo, du Cros, Philipp, Tripathy, Srikanth, Ruhwald, Morten, Singh, Manjula, Denkinger, Claudia M., Schumacher, Samuel G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2021
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607906/
https://www.ncbi.nlm.nih.gov/pubmed/34049948
http://dx.doi.org/10.1183/13993003.00526-2021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607906/
https://www.ncbi.nlm.nih.gov/pubmed/34049948
http://dx.doi.org/10.1183/13993003.00526-2021

Ejemplares similares